Home > Insider Trading > Filing (0001062993-22-014508)

Filing Details

Accession Number:: 0001062993-22-014508
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-06-08 19:13:17
Reporting Period:: 2022-06-06

Accepted Time:: 2022-06-08 19:13:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1661181	Organogenesis Holdings Inc.	ORGO	Biological Products, (No Disgnostic Substances) (2836)	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1074084	Albert Erani	C/O Rugby Realty Co., Inc. 300 Lighting Way, Ste 210 Secaucus NJ 07094	No	No	Yes	No
1757452	Gn 2016 Organo 10-Year Grat U/A/D September 30, 2016	35 Sawgrass Drive Bellport NY 11713	No	No	Yes	No
1760685	Dennis Erani	6000 Island Boulevard Apt. 2502 Aventura FL 33160	No	No	Yes	No
1900525	Red Holdings, Llc	C/O Rugby Realty Co., Inc. 300 Lighting Way, Ste 210 Secaucus NJ 07094	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Disposition	2022-06-06	100,000	$5.41	59,348,027	No	4	S	Direct
Class A Common Stock	Disposition	2022-06-07	50,000	$5.49	59,298,027	No	4	S	Direct
Class A Common Stock	Disposition	2022-06-08	20,000	$5.39	59,278,027	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.30 to $5.55, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.33 to $5.54, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.34 to $5.49, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
Reflects the total number of securities held by the Group. Only Albert Erani has a pecuniary interest in the shares being sold pursuant to this Form 4. None of the other members of the Group has a pecuniary interest in the shares being sold pursuant to this Form 4.